Sertraline hydrochloride and Excessive or unwanted hair in women - a phase IV clinical study of FDA data

Summary:

We study 23,420 people who have side effects when taking Sertraline hydrochloride. Excessive or unwanted hair in women is found, especially among people who are male, 60+ old, also take Alprazolam.

The phase IV clinical study analyzes which people take Sertraline hydrochloride and have Excessive or unwanted hair in women. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 18, 2023

23,420 people reported to have side effects when taking Sertraline hydrochloride.
Among them, 2 people (0.01%) have Excessive or unwanted hair in women.


What is Sertraline hydrochloride?

Sertraline hydrochloride has active ingredients of sertraline hydrochloride. It is used in depression. Currently, eHealthMe is studying from 25,611 Sertraline hydrochloride users.

What is Excessive or unwanted hair in women?

Excessive or unwanted hair in women is found to be associated with 1,196 drugs and 884 conditions by eHealthMe. Currently, we are studying 4,940 people who have Excessive or unwanted hair in women.

Number of Sertraline hydrochloride and Excessive or unwanted hair in women reports submitted per year:

Could Sertraline hydrochloride cause Excessive or unwanted hair in women?

Gender of people who have Excessive or unwanted hair in women when taking Sertraline hydrochloride *:

  • female: 50 %
  • male: 50 %

Age of people who have Excessive or unwanted hair in women when taking Sertraline hydrochloride *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %


Common drugs people take besides Sertraline hydrochloride *:

  1. Theophylline: 1 person, 50.00%
  2. Premarin: 1 person, 50.00%
  3. Pantoprazole: 1 person, 50.00%
  4. Celebrex: 1 person, 50.00%
  5. Alprazolam: 1 person, 50.00%

Common side effects people have besides Excessive or unwanted hair in women *:

  1. Rash Erythematous (redness of the skin): 1 person, 50.00%
  2. Osteoporosis (bones weak and more likely to break): 1 person, 50.00%
  3. Fatigue (feeling of tiredness): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Sertraline hydrochloride and have Excessive or unwanted hair in women?

Check whether Excessive or unwanted hair in women is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Sertraline hydrochloride side effects by duration, gender and age:

Excessive or unwanted hair in women treatments and more:

Common drugs associated with Excessive or unwanted hair in women:

All the drugs that are associated with Excessive or unwanted hair in women:

Common conditions associated with Excessive or unwanted hair in women:

All the conditions that are associated with Excessive or unwanted hair in women:

How the study uses the data?

The study uses data from the FDA. It is based on sertraline hydrochloride (the active ingredients of Sertraline hydrochloride) and Sertraline hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: